FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)

After bankruptcy filing, Purdue Pharma may not be off hook

September 16, 2019 - 2:09 am

OxyContin maker Purdue Pharma has filed for bankruptcy protection.

But that doesn't mean the company or the family that owns it is off the legal hook.

States are divided on whether to accept a tentative settlement with the company as part of the bankruptcy.

Several of those who have declined it have made it clear that they plan to object to the bankruptcy and push forward with their claims against members of the Sackler family in state court.

It will be up to a bankruptcy judge to decide if those suits can move ahead. And even if he stops them, he could consider their claims in his court.

The bankruptcy filing Sunday will likely get Purdue out of a trial over the toll of opioids scheduled for October in Cleveland.


Mulvihill reported from Cherry Hill, New Jersey.


Follow Geoff Mulvihill at

AP Editorial Categories: 
Comments ()